1. Jones WD, Dafou D, McEntagart M, Woollard WJ, Elmslie FV, Holder-Espinasse M, et al. De novo mutations in MLL cause Wiedemann-Steiner syndrome. Am J Hum Genet. 2012; 91:358–64.
Article
2. Aggar wal A, Rodriguez-Buritica DF, Northrup H. Wiedemann-Steiner syndrome: novel pathogenic variant and review of literature. Eur J Med Genet. 2017; 60:285–8.
Article
3. Stoyle G, Banka S, Langley C, Jones EA, Banerjee I. Growth hormone deficiency as a cause for short stature in Wiedemann-Steiner Syndrome. Endocrinol Diabetes Metab Case Rep. 2018; 2018:18–0085.
Article
4. Baer S, Afenjar A, Smol T, Piton A, Gerard B, Alembik Y, et al. Wiedemann-Steiner syndrome as a major cause of syndromic intellectual disability: a study of 33 French cases. Clin Genet. 2018; 94:141–52.
Article
5. Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015; 17:405–24.
Article
6. Ramirez-Montano D, Pachajoa H. Wiedemann-Steiner syndrome with a novel pathogenic variant in KMT2A: a case report. Colomb Med (Cali). 2019; 50:40–5.
7. Schott DA, Gerver WJM, Stumpel C. Growth hormone therapy in children with Kabuki syndrome: 1-year treatment results. Horm Res Paediatr. 2017; 88:258–64.
Article
8. Zentner GE, Layman WS, Martin DM, Scacheri PC. Molecular and phenotypic aspects of CHD7 mutation in CHARGE syndrome. Am J Med Genet A. 2010; 152A:674–86.
9. Hirst L, Evans R. Wiedemann-Steiner syndrome: A case report. Clin Case Rep. 2021; 9:1158–62.
Article
10. Ko JM, Cho JS, Yoo Y, Seo J, Choi M, Chae JH, et al. Wiedemann-Steiner syndrome with 2 novel KMT2A mutations. J Child Neurol. 2017; 32:237–42.